AC
The startup develops low-molecular-weight drugs targeting allergic diseases by utilizing small molecular treatment systems that operate at the molecular and cellular levels. This approach provides patients with effective therapeutic options for managing atopic diseases.
Updated 3 months ago
Funding
$4.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops low-molecular-weight drugs targeting allergic diseases by utilizing small molecular treatment systems that operate at the molecular and cellular levels. This approach provides patients with effective therapeutic options for managing atopic diseases.